Cvs Corp. (NYSE:CVS): CVS Caremark disclosed in a regulatory filing that in January, the company received a subpoena from OIG requesting information about its Health Savings Pass program, a prescription drug discount program for uninsured or under insured individuals, in connection with an investigation of possible false or otherwise improper claims for payment involving HHS programs. In February, CVS said it also received a civil investigative demand from the Office of the Attorney General of the State of Texas requesting a copy of information produced under this OIG subpoena and other information related to prescription drug claims submitted by our pharmacies to Texas Medicaid for reimbursement. The company will respond to these requests for information and cooperate with each of these investigations, and cannot predict the timing or outcome of any review by the applicable government agency of the requested information, CVS said. The shares closed at $44.27, down $0.28 or 0.63% on the day. They have traded in a 52-week range of $31.30 to $44.56.

Amylin Pharmaceutica (NASDAQ:AMLN): Amylin Pharmaceuticals (NASDAQ:AMLN) and Eli Lilly and Company (NYSE:LLY) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA as an add-on therapy to basal insulin, with or without metformin and/or Actos, for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents. The CHMP’s decision is now referred for final action to the European Commission, which has the authority to approve medicines for the EU. The Commission usually decides on CHMP recommendations within two to three months, the companies said. The shares closed at $17.70, down $0.37 or 2.05% on the day. They have traded in a 52-week range of $8.03 to $18.35.

Barnes Group (NYSE:B): Sees FY12 revenue up 6%-9% from 2011 vs. consensus $1.34B. Sees FY12 operating margins approx. 12%, CapEx $45M-$50M. The shares closed at $27.80, up $1.34 or 5.06% on the day. They have traded in a 52-week range of $17.47 to $27.13.

Borgwarner Inc. (NYSE:BWA): Sterne Agee increased its target on BorgWarner after the company reported higher than expected Q4 results and provided higher than expected 2012 EPS guidance. The firm thinks that the company should grow by double digit levels oer the next few years and it maintains a Buy rating. The shares closed at $81.21, down $0.7 or 0.85% on the day. They have traded in a 52-week range of $54.59 to $82.10.

Centene Corp. (NYSE:CNC): The Obama administration yesterday denied Wisconsin’s request for a waiver on the health care law’s medical loss ratio rules, but allowed North Carolina to impose a medical loss ratio requirement of 75% in 2011, versus the law’s requirement of 80%, according to The Hill. The medical loss ratio percentages refer to the amount of premiums that insurers must spend on medical care. The Obama administration has granted waivers on the rule to seven states, the publication said. The shares closed at $49.74, down $0.01 or 0.02% on the day. They have traded in a 52-week range of $25.28 to $50.00.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com

Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!